| RS1555814477 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS1555814719 |
PRKAR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Carney complex, type 1 |
| RS1555815121 |
PRKAR1A
|
Health Risk |
Likely pathogenic |
Acrodysostosis 1 with or without hormone resistance, Carney complex |
| RS1555815158 |
HNF4A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1555815238 |
PIK3R2
|
Health Risk |
Likely pathogenic |
— |
| RS1555815393 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1555815396 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1555815437 |
SPTBN4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555816615 |
HNF4A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young |
| RS1555816634 |
KANK2
|
Health Risk |
Pathogenic |
Nephrotic syndrome 16, Nephrotic syndrome 16 |
| RS1555816642 |
HNF4A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1555816654 |
HNF4A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 1, Monogenic diabetes |
| RS1555817157 |
ABHD12
|
Health Risk |
Pathogenic |
PHARC syndrome, PHARC syndrome |
| RS1555817727 |
HNF4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Monogenic diabetes |
| RS1555817851 |
HNF4A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1555818396 |
SPTBN4
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, neuropathy |
| RS1555821665 |
HNF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1555821817 |
COL9A3
|
Health Risk |
Likely pathogenic |
Epiphyseal dysplasia, multiple |
| RS1555826433 |
MAFB
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1555826446 |
MAFB
|
Health Risk |
Pathogenic |
— |
| RS1555826472 |
DOCK6
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 2, Adams-Oliver syndrome 2 |
| RS1555827650 |
JAG1
|
Health Risk |
Pathogenic |
Arteriohepatic dysplasia, Arteriohepatic dysplasia |
| RS1555827653 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1555827717 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1555827729 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1555827760 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1555827769 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1555827782 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1555827789 |
JAG1
|
Health Risk |
Pathogenic |
Atypical coarctation of aorta, Alagille syndrome due to a JAG1 point mutation |
| RS1555827790 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1555828173 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1555828209 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1555828250 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1555828321 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1555828546 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1555828577 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1555828589 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1555828640 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1555828646 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1555828652 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1555828721 |
JAG1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1555828770 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1555828843 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1555829037 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1555829039 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1555829065 |
JAG1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1555829415 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1555829660 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1555830002 |
HNF1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal cysts and diabetes syndrome, Renal cysts and diabetes syndrome |
| RS1555830705 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Leber plus disease, Leber plus disease |
| RS1555830919 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1555830922 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1555830929 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1555830976 |
JAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1555831004 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Arteriohepatic dysplasia, Arteriohepatic dysplasia |
| RS1555831014 |
JAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1555831433 |
HNF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1555832998 |
HNF1B
|
Health Risk |
Pathogenic |
Renal cysts and diabetes syndrome, Renal cysts and diabetes syndrome |
| RS1555833051 |
HNF1B
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Monogenic diabetes, Maturity-onset diabetes of the young |
| RS1555833071 |
HNF1B
|
Health Risk |
Pathogenic |
Hyperuricemic nephropathy, familial juvenile type 3 |
| RS1555833144 |
HNF1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal cysts and diabetes syndrome, Maturity-onset diabetes of the young |
| RS1555834773 |
NDUFAF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS1555836169 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1555836170 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Spastic tetraplegia and axial hypotonia |
| RS1555836520 |
SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1555836803 |
SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1555836889 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1555836950 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1555837082 |
KCNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 6, Cardiovascular phenotype |
| RS1555837861 |
ADAT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-strabismus syndrome, Intellectual disability-strabismus syndrome |
| RS1555837911 |
CHRNA4
|
Health Risk |
Likely pathogenic |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS1555839022 |
RPS19
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1555839154 |
RPS19
|
Health Risk |
Pathogenic |
— |
| RS1555839161 |
RPS19
|
Health Risk |
Pathogenic |
— |
| RS1555839190 |
RPS19
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1555839474 |
PLCB4
|
Health Risk |
Likely pathogenic |
— |
| RS1555841301 |
RPS19
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, RPS19-related disorder |
| RS1555841307 |
RPS19
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1555841356 |
RPS19
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia 1 |
| RS1555841379 |
RPS19
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia 1, Diamond-Blackfan anemia 1 |
| RS1555841598 |
RPS19
|
Health Risk |
Pathogenic |
— |
| RS1555841710 |
CLDN14
|
Health Risk |
Likely pathogenic |
— |
| RS1555841977 |
LOC102724428
|
Health Risk |
Pathogenic |
Self-limited epilepsy with centrotemporal spikes, Self-limited epilepsy with centrotemporal spikes |
| RS1555843178 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1555843601 |
CD79A
|
Health Risk |
Likely pathogenic |
Agammaglobulinemia 3, autosomal recessive |
| RS1555843898 |
KCNE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome, Cardiovascular phenotype |
| RS1555843953 |
KCNE1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1555844006 |
ADA
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1555844063 |
CD79A
|
Health Risk |
Likely pathogenic |
Agammaglobulinemia 3, autosomal recessive |
| RS1555844120 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1555844395 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1555844416 |
ADA
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency, autosomal recessive |
| RS1555844600 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1555844616 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1555844617 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1555845120 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1555845122 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1555850151 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial neonatal |
| RS1555850403 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS1555850512 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |